Belpointe Asset Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-10,680
Closed -$149K 755
2023
Q3
$149K Sell
10,680
-1,142
-10% -$14.6K 0.02% 617
2023
Q2
$139K Sell
11,822
-2,063
-15% -$23.5K 0.01% 585
2023
Q1
$160K Sell
13,885
-3,716
-21% -$46K 0.01% 1047
2022
Q4
$219K Sell
17,601
-1,547
-8% -$19.7K 0.01% 857
2022
Q3
$251K Buy
19,148
+521
+3% +$7.7K 0.02% 750
2022
Q2
$260K Sell
18,627
-809
-4% -$10.8K 0.02% 728
2022
Q1
$289K Sell
19,436
-346
-2% -$4.73K 0.02% 739
2021
Q4
$268K Sell
19,782
-718
-4% -$10.2K 0.02% 764
2021
Q3
$301K Sell
20,500
-4
-0% -$68 0.02% 680
2021
Q2
$373K Sell
20,504
-658
-3% -$11.7K 0.03% 594
2021
Q1
$367K Buy
21,162
+679
+3% +$11.9K 0.03% 523
2020
Q4
$356K Sell
20,483
-767
-4% -$12.2K 0.03% 500
2020
Q3
$293K Buy
21,250
+82
+0.4% +$1.2K 0.03% 444
2020
Q2
$305K Buy
21,168
+86
+0.4% +$1.13K 0.04% 402
2020
Q1
$230K Sell
21,082
-389
-2% -$7.17K 0.04% 399
2019
Q4
$458K Buy
21,471
+2,061
+11% +$46.1K 0.06% 338
2019
Q3
$446K Buy
+19,410
New +$414K 0.07% 310

Other funds holding SBRA

Belpointe Asset Management's SBRA Position: Q4 2023 in Review

Belpointe Asset Management sold out of Sabra Healthcare REIT (SBRA) in Q4 2023, closing a stake of 10,680 shares — an estimated $149K sold.

Belpointe Asset Management first reported a position in SBRA in Q3 2019 and held it in 17 quarters. The position peaked at $458K in Q4 2019. 359 funds tracked by Wall St. Rank hold SBRA as of Q4 2023.

  • Belpointe Asset Management reported no remaining Sabra Healthcare REIT position as of Q4 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 10,680 Sabra Healthcare REIT shares in Q4 2023, an estimated $149K.
  • Belpointe Asset Management first reported a position in Sabra Healthcare REIT in Q3 2019 and held it in 17 quarters.
  • Belpointe Asset Management's Sabra Healthcare REIT position peaked at $458K in Q4 2019.
  • 359 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2023.

Based on Belpointe Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.